Published in Eur J Epidemiol on April 01, 2000
Mediterranean diet and risk for Alzheimer's disease. Ann Neurol (2006) 4.38
Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal (2013) 2.34
A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal (2012) 2.03
Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal (2012) 1.96
Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients (2010) 1.66
The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr (2008) 1.61
Associations of vegetable and fruit consumption with age-related cognitive change. Neurology (2006) 1.57
Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med (2006) 1.52
Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study. BMJ (2004) 1.51
Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr (2011) 1.45
Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proc Natl Acad Sci U S A (2008) 1.42
Flavonoids and brain health: multiple effects underpinned by common mechanisms. Genes Nutr (2009) 1.40
Dietary approaches that delay age-related diseases. Clin Interv Aging (2006) 1.37
Inflammaging as a prodrome to Alzheimer's disease. J Neuroinflammation (2008) 1.29
Moderate alcohol consumption and cognitive risk. Neuropsychiatr Dis Treat (2011) 1.26
Dietary antioxidants and long-term risk of dementia. Arch Neurol (2010) 1.11
Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. Curr Psychiatry Rev (2009) 1.09
Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxid Med Cell Longev (2012) 1.08
Increasing fruit and vegetable intake in homebound elders: the Seattle Senior Farmers' Market Nutrition Pilot Program. Prev Chronic Dis (2003) 1.08
Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging. Alzheimers Dement (2005) 1.07
Neuroprotective potential of phytochemicals. Pharmacogn Rev (2012) 1.05
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance. Br J Clin Pharmacol (2013) 1.02
Maize Lc transcription factor enhances biosynthesis of anthocyanins, distinct proanthocyanidins and phenylpropanoids in apple (Malus domestica Borkh.). Planta (2007) 1.01
Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev Med Chem (2008) 1.00
Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. J Nutr (2010) 0.99
Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma. Front Cell Neurosci (2013) 0.91
Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes Nutr (2011) 0.91
Alcohol and risk of Parkinson's disease in a large, prospective cohort of men and women. Mov Disord (2012) 0.90
Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response (2007) 0.89
Midlife fruit and vegetable consumption and risk of dementia in later life in Swedish twins. Am J Geriatr Psychiatry (2010) 0.89
Dietary supplementation with fruit polyphenolics ameliorates age-related deficits in behavior and neuronal markers of inflammation and oxidative stress. Age (Dordr) (2005) 0.87
Dietary (-)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing. Neurobiol Aging (2014) 0.87
Diet and neurocognition: review of evidence and methodological considerations. Curr Aging Sci (2010) 0.86
Dealing with misfolded proteins: examining the neuroprotective role of molecular chaperones in neurodegeneration. Molecules (2010) 0.86
Effects of Various Flavonoids on the α-Synuclein Fibrillation Process. Parkinsons Dis (2010) 0.86
Flavonoid intake in European adults (18 to 64 years). PLoS One (2015) 0.85
Response of wild-type and high pigment-1 tomato fruit to UV-B depletion: flavonoid profiling and gene expression. Planta (2009) 0.84
Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates. J Biomed Sci (2012) 0.84
Neurohormetic phytochemicals: An evolutionary-bioenergetic perspective. Neurochem Int (2015) 0.83
Can consuming flavonoids restore old microglia to their youthful state? Nutr Rev (2010) 0.83
The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular Dementia. Oxid Med Cell Longev (2015) 0.81
Alcohol use disorders and risk of Parkinson's disease: findings from a Swedish national cohort study 1972-2008. BMC Neurol (2013) 0.81
Molecular and Biochemical Analysis of Chalcone Synthase from Freesia hybrid in flavonoid biosynthetic pathway. PLoS One (2015) 0.81
Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? Oxid Med Cell Longev (2016) 0.80
Plasma carotenoids and tocopherols and cognitive function: a prospective study. Neurobiol Aging (2007) 0.79
Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress. Eur J Nutr (2008) 0.79
Antagonistic effect of alkaloids and saponins on bioactivity in the quinine tree (Rauvolfia caffra sond.): further evidence to support biotechnology in traditional medicinal plants. BMC Complement Altern Med (2013) 0.79
Flavanols, mild cognitive impairment, and Alzheimer's dementia. Int J Clin Exp Med (2008) 0.79
Vanda roxburghii chloroform extract as a potential source of polyphenols with antioxidant and cholinesterase inhibitory activities: identification of a strong phenolic antioxidant. BMC Complement Altern Med (2015) 0.79
Dietary antioxidant intake and its association with cognitive function in an ethnically diverse sample of US adults. Psychosom Med (2015) 0.78
Dietary Factors and Cognitive Decline. J Prev Alzheimers Dis (2016) 0.78
Are certain lifestyle habits associated with lower Alzheimer's disease risk? J Alzheimers Dis (2010) 0.78
Radical scavenging potentials of single and combinatorial herbal formulations in vitro. J Tradit Complement Med (2015) 0.78
Polyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefits. Adv Nutr (2014) 0.77
Elevated gene expression in chalcone synthase enzyme suggests an increased production of flavonoids in skin and synchronized red cell cultures of North American native grape berries. DNA Cell Biol (2012) 0.77
Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanism. Bioinformation (2011) 0.76
Cocoa powder triggers neuroprotective and preventive effects in a human Alzheimer's disease model by modulating BDNF signaling pathway. J Cell Biochem (2013) 0.76
Correlation between antibutyrylcholinesterasic and antioxidant activities of three aqueous extracts from Tunisian Rhus pentaphyllum. Ann Clin Microbiol Antimicrob (2011) 0.75
Association between alcohol and Alzheimer's disease. Exp Ther Med (2016) 0.75
Low-Dose Aronia melanocarpa Concentrate Attenuates Paraquat-Induced Neurotoxicity. Oxid Med Cell Longev (2015) 0.75
A Strategy to Employ Clitoria ternatea as a Prospective Brain Drug Confronting Monoamine Oxidase (MAO) Against Neurodegenerative Diseases and Depression. Nat Prod Bioprospect (2015) 0.75
High-flavonoid intake induces cognitive improvements linked to changes in serum brain-derived neurotrophic factor: Two randomised, controlled trials. Nutr Healthy Aging (2016) 0.75
Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans? Front Pharmacol (2016) 0.75
Sideritis spp. Extracts Enhance Memory and Learning in Alzheimer's β-Amyloidosis Mouse Models and Aged C57Bl/6 Mice. J Alzheimers Dis (2016) 0.75
Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach. Front Neurosci (2017) 0.75
Dietary phytochemical intake from foods and health outcomes: a systematic review protocol and preliminary scoping. BMJ Open (2017) 0.75
Enhancing Human Cognition with Cocoa Flavonoids. Front Nutr (2017) 0.75
Cognitive and mood improvements following acute supplementation with purple grape juice in healthy young adults. Eur J Nutr (2017) 0.75
Unraveling the performance of dispersion-corrected functionals for the accurate description of weakly bound natural polyphenols. J Mol Model (2015) 0.75
The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation. Sci Rep (2017) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med (1989) 15.67
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet (1993) 6.53
Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA (1996) 4.29
Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet (1979) 4.10
Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol (1997) 3.90
Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med (1997) 3.74
Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol (1997) 2.67
Dietary antioxidants and cognitive function in a population-based sample of older persons. The Rotterdam Study. Am J Epidemiol (1996) 2.45
Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry (1999) 2.33
Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr (1997) 2.14
Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol (1997) 1.81
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) (1997) 1.77
Modelling age-specific risk: application to dementia. Stat Med (1998) 1.74
The Paquid epidemiological program on brain ageing. Neuroepidemiology (1992) 1.51
Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm (Vienna) (1998) 1.35
Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med (1996) 1.30
Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. Am J Epidemiol (1998) 1.25
Dietary antioxidants and Parkinson disease. The Rotterdam Study. Arch Neurol (1997) 1.05
Effects of alcohol on platelet functions. Clin Chim Acta (1996) 1.02
Re: "Serum transferrin saturation, stroke incidence, and mortality in women and men. The NHANES I Epidemiologic Followup Study". Am J Epidemiol (1997) 1.01
Alcohol-free red wine enhances plasma antioxidant capacity in humans. J Nutr (1998) 0.95
An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet (1998) 0.94
Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol (1997) 0.91
Free radicals in Alzheimer's dementia: currently available therapeutic strategies. J Neural Transm Suppl (1998) 0.87
Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease. Dement Geriatr Cogn Disord (1998) 0.82
Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease. Life Sci (1997) 0.78
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet (1994) 9.13
Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology (1999) 3.95
The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol (1991) 3.70
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology (2002) 3.57
Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc (1995) 3.51
Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 3.39
Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 3.14
Restriction in complex activities of daily living in MCI: impact on outcome. Neurology (2006) 2.64
A 5-year longitudinal study of the Mini-Mental State Examination in normal aging. Am J Epidemiol (1997) 2.50
Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.45
Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology (2000) 2.43
Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry (1999) 2.33
Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke (1991) 2.19
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. EURODEM Incidence Research Group. Neurology (1999) 2.13
Dietary patterns and risk of dementia: the Three-City cohort study. Neurology (2007) 2.09
A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Cephalalgia (1992) 2.05
Incidence of dementia and Alzheimer's disease in elderly community residents of south-western France. Int J Epidemiol (1994) 1.96
Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980-1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol (1991) 1.89
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) (1997) 1.77
Modelling age-specific risk: application to dementia. Stat Med (1998) 1.74
Long-term prognosis in two forms of childhood epilepsy: typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci. Ann Neurol (1983) 1.64
Components of drinking water and risk of cognitive impairment in the elderly. Am J Epidemiol (1994) 1.64
Body mass index and incidence of dementia: the PAQUID study. Neurology (2003) 1.63
Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol (2007) 1.60
Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting. J Nutr Health Aging (2013) 1.57
Temperature and risk factors for ischaemic heart disease in the Caerphilly prospective study. Br Heart J (1993) 1.52
Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc (1992) 1.52
The Paquid epidemiological program on brain ageing. Neuroepidemiology (1992) 1.51
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology (2005) 1.50
Olive oil consumption, plasma oleic acid, and stroke incidence: the Three-City Study. Neurology (2011) 1.48
Measuring cognitive change in subjects with prodromal Alzheimer's disease. J Neurol Neurosurg Psychiatry (2013) 1.48
The neuroprotective effects of caffeine: a prospective population study (the Three City Study). Neurology (2007) 1.47
The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients. Transplantation (1994) 1.45
IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging (2007) 1.44
[The Paquid research program on the epidemiology of dementia. Methods and initial results]. Rev Neurol (Paris) (1991) 1.43
Effect of smoking on global cognitive function in nondemented elderly. Neurology (2004) 1.42
Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol (2001) 1.42
Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. Am J Epidemiol (1996) 1.41
Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors. Neurology (2012) 1.41
Effects of a French Mediterranean diet on heart transplant recipients with hypercholesterolemia. Am J Cardiol (1994) 1.40
Functional impairment in instrumental activities of daily living: an early clinical sign of dementia? J Am Geriatr Soc (1999) 1.40
Initial factors predicting functional performance in patients with traumatic tetraplegia. Paraplegia (1990) 1.40
Accelerated coronary artery disease after heart transplantation: the role of enhanced platelet aggregation and thrombosis. J Intern Med (1993) 1.39
Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol (1993) 1.39
Blood lead and platelet aggregation--evidence for a causal association. Thromb Haemost (1991) 1.39
Frequency of severe attacks in migraine sufferers of the Gazel cohort. Cephalalgia (1997) 1.38
HIV infection and immune system in genesis of coronary lesions. Lancet (1992) 1.38
Dementia case management effectiveness on health care costs and resource utilization: a systematic review of randomized controlled trials. J Nutr Health Aging (2010) 1.36
Modeling changes in CD4-positive T-lymphocyte counts after the start of highly active antiretroviral therapy and the relation with risk of opportunistic infections: the Aquitaine Cohort, 1996-1997. Am J Epidemiol (2001) 1.35
Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study. Am J Epidemiol (2000) 1.30
Cognitive process in preclinical phase of dementia. Brain (1998) 1.29
The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain (2001) 1.29
Familial aggregation of Parkinson's disease: a population-based case-control study in Europe. EUROPARKINSON Study Group. Neurology (1999) 1.29
Acute myocardial infarction in dogs with experimental diabetes. Cardiovasc Res (1993) 1.28
Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. Am J Epidemiol (1998) 1.25
Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia. Compr Psychiatry (2003) 1.25
Self-reported memory complaints and memory performance in elderly French community residents: results of the PAQUID Research Program. Neuroepidemiology (1994) 1.24
A randomized controlled trial of cognitive therapy versus intensive behavior therapy in obsessive compulsive disorder. Psychother Psychosom (2001) 1.24
Prevalence of Parkinson's disease in the elderly: a population study in Gironde, France. Acta Neurol Scand (1994) 1.23
Occupation during life and risk of dementia in French elderly community residents. J Neurol Neurosurg Psychiatry (2001) 1.22
Subjective health and mortality in French elderly women and men. J Gerontol B Psychol Sci Soc Sci (1999) 1.21
Electrogram patterns predictive of successful catheter ablation of accessory pathways. Value of unipolar recording mode. Circulation (1991) 1.21
Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study. Proc Natl Acad Sci U S A (1996) 1.21
A hierarchical model of domains of disablement in the elderly: a longitudinal approach. Disabil Rehabil (2000) 1.21
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol (2001) 1.19
Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci U S A (2001) 1.17
Viral load as a primary outcome in human immunodeficiency virus trials: a review of statistical analysis methods. Control Clin Trials (2001) 1.12
Disability and handicap 5 years after a head injury: a population-based study. J Clin Epidemiol (1997) 1.12
Spinal cord injuries--epidemiology in Portugal's central region. Spinal Cord (1998) 1.12
Relationship between body mass index and different domains of disability in older persons: the 3C study. Int J Obes Relat Metab Disord (2004) 1.12
Social relations and depressive symptomatology in a sample of community-dwelling French older adults. Psychol Aging (1997) 1.12
Marital status and risk of Alzheimer's disease: a French population-based cohort study. Neurology (1999) 1.11
Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res (2009) 1.11
Evaluation of ticlopidine, a novel inhibitor of platelet aggregation, in heart transplant recipients. Transplantation (1993) 1.11
TNF-alpha expression in painful and nonpainful neuropathies. Neurology (2001) 1.11
Neuropsychologic effects of long-term exposure to pesticides: results from the French Phytoner study. Environ Health Perspect (2001) 1.10
Prevalence of diabetes and effect on quality of life in older French living in the community: the PAQUID Epidemiological Survey. J Am Geriatr Soc (1997) 1.10
[Development of a neurological score for the clinical evaluation of sylvian infarctions]. Presse Med (1983) 1.09
Flexor tendon sheath ganglion: analysis of 128 cases. Hand Surg (2004) 1.09
Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J Nutr Health Aging (2004) 1.08
Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study. J Clin Epidemiol (1996) 1.08